{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:10:19Z","timestamp":1786749019177,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.japh.2023.03.001","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T11:48:36Z","timestamp":1678362516000},"page":"885-892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Public health detailing to increase naloxone access in NYC pharmacies"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-8044","authenticated-orcid":false,"given":"Carla L.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellenie","family":"Tuazon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-5865","authenticated-orcid":false,"given":"Emily","family":"Winkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary V.","family":"Kunins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2023.03.001_bib1","unstructured":"Li W, Onyebeke C, Huynh M, et al. Summary of vital statistics 2019. Bureau of Vital Statistics, New York City Department of Health and Mental Hygiene. Available at: https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/vs\/2019sum.pdf. Accessed December 13, 2021."},{"key":"10.1016\/j.japh.2023.03.001_bib2","unstructured":"Nolan ML, Mantha S, Tuazon E, Paone D. Unintentional drug poisoning (overdose) deaths in New York City in 2018. New York City Department of Health and Mental Hygiene. Epi Data Brief. Available at: https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/epi\/databrief116.pdf. Accessed September 30, 2021."},{"issue":"7569","key":"10.1016\/j.japh.2023.03.001_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.333.7569.614","article-title":"Emergency naloxone for heroin overdose","volume":"333","author":"Strang","year":"2006","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.japh.2023.03.001_bib4","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.japh.2023.03.001_bib8","first-page":"CD000409","article-title":"Educational outreach visits: effects on professional practice and health care outcomes","volume":"2007","author":"O\u2019Brien","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 3","key":"10.1016\/j.japh.2023.03.001_bib9","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.2105\/AJPH.2011.300622","article-title":"Public health detailing of primary care providers: New York City\u2019s experience, 2003\u20132010","volume":"102","author":"Dresser","year":"2012","journal-title":"Am J Public Health"},{"issue":"8","key":"10.1016\/j.japh.2023.03.001_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2105\/AJPH.2016.303274","article-title":"Public health detailing-a successful strategy to promote judicious opioid analgesic prescribing","volume":"106","author":"Kattan","year":"2016","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.japh.2023.03.001_bib11","first-page":"122","article-title":"Academic detailing pilot for naloxone prescribing among primary care providers in San Francisco","volume":"49","author":"Behar","year":"2017","journal-title":"Fam Med"},{"issue":"2S","key":"10.1016\/j.japh.2023.03.001_bib12","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.japh.2016.11.003","article-title":"Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: a preliminary analysis","volume":"57","author":"Bounthavong","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"8","key":"10.1016\/j.japh.2023.03.001_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.sapharm.2019.10.015","article-title":"Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: a qualitative assessment","volume":"16","author":"Bounthavong","year":"2020","journal-title":"Res Social Adm Pharm"},{"issue":"11","key":"10.1016\/j.japh.2023.03.001_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11916-018-0730-4","article-title":"Naloxone academic detailing: role of community outreach teaching","volume":"22","author":"Abd-Elsayed","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.japh.2023.03.001_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.japh.2019.09.007","article-title":"Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas","volume":"60","author":"Evoy","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2023.03.001_bib16","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.japh.2021.01.031","article-title":"Academic detailing with ambulatory pharmacists to support naloxone counseling","volume":"61","author":"Kennedy","year":"2021","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2023.03.001_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.japh.2022.12.001","article-title":"Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician","volume":"63","author":"Irwin","year":"2023","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2023.03.001_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.japh.2021.09.012","article-title":"Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction","volume":"62","author":"DiPaula","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2023.03.001_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.sapharm.2018.10.028","article-title":"Just the fax, please: updating electronic\/hybrid methods for surveying pharmacists","volume":"15","author":"Agley","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"10.1016\/j.japh.2023.03.001_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/003335490612100302","article-title":"Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City","volume":"121","author":"Larson","year":"2006","journal-title":"Public Health Rep"},{"key":"10.1016\/j.japh.2023.03.001_bib22","author":"Nolan"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:05Z","timestamp":1761544325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1544319123000638"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.03.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Public health detailing to increase naloxone access in NYC pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}